ATE204385T1 - Immunoassays unter verwendung von markierten hapten-analogen - Google Patents

Immunoassays unter verwendung von markierten hapten-analogen

Info

Publication number
ATE204385T1
ATE204385T1 AT92201582T AT92201582T ATE204385T1 AT E204385 T1 ATE204385 T1 AT E204385T1 AT 92201582 T AT92201582 T AT 92201582T AT 92201582 T AT92201582 T AT 92201582T AT E204385 T1 ATE204385 T1 AT E204385T1
Authority
AT
Austria
Prior art keywords
immunoassays
drug
analogues
labeled hapten
label
Prior art date
Application number
AT92201582T
Other languages
English (en)
Inventor
Susan Jean Danielson
Barbara A Brummond
Marsha D Oenick
Ignazio Salvatore E Ponticello
David Alan Hilborn
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Application granted granted Critical
Publication of ATE204385T1 publication Critical patent/ATE204385T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/816Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92201582T 1991-06-07 1992-06-02 Immunoassays unter verwendung von markierten hapten-analogen ATE204385T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71232891A 1991-06-07 1991-06-07
US85143692A 1992-03-16 1992-03-16

Publications (1)

Publication Number Publication Date
ATE204385T1 true ATE204385T1 (de) 2001-09-15

Family

ID=27108808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92201582T ATE204385T1 (de) 1991-06-07 1992-06-02 Immunoassays unter verwendung von markierten hapten-analogen

Country Status (5)

Country Link
US (1) US5601994A (de)
EP (1) EP0517327B1 (de)
JP (1) JP3190730B2 (de)
AT (1) ATE204385T1 (de)
DE (1) DE69232002T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0576095B1 (de) * 1992-06-26 1999-01-27 Johnson & Johnson Clinical Diagnostics, Inc. Immunotests unter Verwendung von markierten Thyronin-Analogen
JP3022942B2 (ja) * 1992-08-07 2000-03-21 イーストマン コダック カンパニー 新規標識カルバマゼピン類似体
US5565326A (en) 1994-05-31 1996-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Separation-free specific binding assays using anti-inhibitor antibodies
US5650324A (en) 1994-05-31 1997-07-22 Johnson & Johnson Clinical Diagnostics, Inc. Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
US5589344A (en) 1994-06-15 1996-12-31 Johnson & Johnson Clinical Diagnostics, Inc. Test kit and method for competitive specific binding assay
AU697785B2 (en) 1994-07-19 1998-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Analytical element,composition and method using modified apo-horseradish peroxidase
ES2167278B1 (es) * 2000-10-24 2003-08-16 Univ Murcia Enzima con actividad peroxidasa aislada de la alcachofa (cynara scolymus, l.) procedimiento para su aislamiento y purificacion y aplicaciones.
US8133743B2 (en) 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay
JP6374387B2 (ja) 2012-08-21 2018-08-15 ヤンセン ファーマシューティカ エヌ.ベー. リスペリドンハプテンへの抗体及びその使用
AU2013305965B2 (en) 2012-08-21 2017-08-24 Saladax Biomedical Inc. Antibodies to paliperidone and use thereof
TR201816416T4 (tr) 2012-08-21 2018-11-21 Janssen Pharmaceutica Nv Risperidona yönelik antikorlar ve bunların kullanımı.
CA2882489A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
CN104755093B (zh) 2012-08-21 2018-11-16 詹森药业有限公司 奥氮平半抗原的抗体及其用途
CN108431040B (zh) 2015-12-17 2022-07-26 詹森药业有限公司 利培酮的抗体及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US4065354A (en) * 1974-10-10 1977-12-27 Syva Company Lysozyme conjugates for enzyme immunoassays
US4213964A (en) * 1978-12-07 1980-07-22 Miles Laboratories, Inc. Diphenylhydantoin antibodies
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
US4404366A (en) * 1980-05-06 1983-09-13 Miles Laboratories, Inc. Beta-galactosyl-umbelliferone-labeled hapten conjugates
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4447529A (en) * 1981-07-06 1984-05-08 Miles Laboratories, Inc. Preparing homogeneous specific binding assay element to avoid premature reaction
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
CA1300499C (en) * 1987-08-03 1992-05-12 Susan J. Danielson Water-insoluble reagent, elements containing same and methods of use
EP0386644B1 (de) * 1989-03-10 1997-06-04 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Reagenzien zum Nachweis von Drogen
US5096838A (en) * 1989-11-27 1992-03-17 Abbott Laboratories Barbiturate assay compositions and methods
US5162219A (en) * 1990-06-18 1992-11-10 Eastman Kodak Company Preparation of amine-enriched proteins having an increased isoelectric point

Also Published As

Publication number Publication date
EP0517327A3 (en) 1993-05-05
JPH0627108A (ja) 1994-02-04
EP0517327A2 (de) 1992-12-09
EP0517327B1 (de) 2001-08-16
JP3190730B2 (ja) 2001-07-23
US5601994A (en) 1997-02-11
DE69232002T2 (de) 2002-06-06
DE69232002D1 (de) 2001-09-20

Similar Documents

Publication Publication Date Title
ATE204385T1 (de) Immunoassays unter verwendung von markierten hapten-analogen
DE68919565D1 (de) Immuntestverfahren unter Verwendung magnetischer Markerteilchen.
ATE233003T1 (de) Verfahren und gerät zum automatischen zusammenfassen von texten
NO851516L (no) Krysstang-kvadrupolkilde for akustisk broennlogging.
FR2624719B1 (fr) Sonde de percage, en particulier pour positionner et fixer un clou medullaire
DE69333569D1 (de) Magnetisch assistierte bindungsassays unter verwendung von magnetisch markierten bindungspartnern.
DE68922243D1 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde.
KR890006584A (ko) 헤테로이작용성 커플링제
FR2582030B3 (fr) Dispositif d'arret antisismique pour structures de poutrelles de ponts, viaducs et similaires
ATE208042T1 (de) Hapten-analoge zur verwendung in immunoassays
ATE134039T1 (de) Analyse von hämoglobinvarianten durch kapillarelektroforese
FR2702105B1 (fr) Dispositif de régulation de la tension de mode commun en sortie d'un amplificateur équilibré.
ATE204384T1 (de) Markierte hapten-analoge zur verwendung in immunoassays
DE68914094D1 (de) Immunoanalyseverfahren.
ATE176329T1 (de) Immunotests unter verwendung von markierten thyronin-analogen
DE69021921D1 (de) Monoklonale Antikörper gegen den C-Terminus von ANP.
FI892257A0 (fi) Anordning foer infoerande, pressning och uttagning av ett skiktpaket i resp. ur en varmpress.
NO890116L (no) Monoklonale antistoffer.
DE69008406D1 (de) N-Hydroxycarbyloxy-Derivate von s-Triazinen mit gehinderter Aminogruppe.
ATE161962T1 (de) Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen
DE69000908D1 (de) Leichtes transportables brueckenteil zur ueberwindung von graeben.
IT8821702A0 (it) Nuovo anticorpo monoclonale.
FR2610957B1 (fr) Piquet pour la fixation au sol d'une borne ou autre repere, et procede pour sa mise en place
FI893928A7 (fi) Monoklonala motkroppar.
ITRM910547A0 (it) Medoto per la rivelazione di anticorpi contro il virus dell'epatite c e corredi per la sua realizzazione